These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26966370)

  • 21. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis.
    Weng M; Zhang Y; Zhou D; Yang Y; Tang Z; Zhao M; Quan Z; Gong W
    PLoS One; 2012; 7(9):e45493. PubMed ID: 23029051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma in the elderly: Meta-analysis and systematic literature review.
    Hung AK; Guy J
    World J Gastroenterol; 2015 Nov; 21(42):12197-210. PubMed ID: 26576104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined resection and radiofrequency ablation versus transarterial embolization for intermediate-stage hepatocellular carcinoma: A propensity score matching study.
    Espinosa W; Liu YW; Wang CC; Lin CC; Wang JH; Lu SN; Hung CH
    J Formos Med Assoc; 2018 Mar; 117(3):197-203. PubMed ID: 28411877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
    Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
    J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies.
    Eriguchi T; Takeda A; Tateishi Y; Tsurugai Y; Sanuki N; Ebinuma H; Horita N
    Hepatol Res; 2021 Jul; 51(7):813-822. PubMed ID: 33856722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis.
    Si MB; Yan PJ; Hao XY; Du ZY; Tian HW; Yang J; Han CW; Yang KH; Guo TK
    Surg Endosc; 2019 Aug; 33(8):2419-2429. PubMed ID: 30989373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiofrequency ablation combined with transcatheter arterial chemoembolization therapy versus surgical resection for Barcelona-Clinic Liver Cancer (BCLC) A hepatocellular carcinoma: a meta-analysis.
    Wang W; Hou S; Zhong Z; Ni J; Jiang X; Chen D; Chen Y; Luo J; Sun H; Xu L
    J Interv Med; 2018 Feb; 1(1):49-57. PubMed ID: 35586344
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiofrequency ablation vs. surgical resection for resectable hepatocellular carcinoma: A systematic review and meta-analysis.
    Li JK; Liu XH; Cui H; Xie XH
    Mol Clin Oncol; 2020 Jan; 12(1):15-22. PubMed ID: 31814972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
    Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis.
    Cui R; Yu J; Kuang M; Duan F; Liang P
    J Cancer Res Ther; 2020; 16(2):379-386. PubMed ID: 32474527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients.
    Hocquelet A; Balageas P; Laurent C; Blanc JF; Frulio N; Salut C; Cassinotto C; Saric J; Possenti L; Bernard PH; Montaudon M; Trillaud H
    Int J Hyperthermia; 2015; 31(7):749-57. PubMed ID: 26365503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of liver stiffness measurement in patients with hepatocellular carcinoma (HCC) treated by radiofrequency ablation: a meta-analysis.
    Zhang Y; Chen H; Chen S; Li W
    Int J Hyperthermia; 2021; 38(1):1052-1059. PubMed ID: 34251953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of radiofrequency ablation and percutaneous ethanol injection versus radiofrequency ablation alone for hepatocellular carcinoma: a systematic review and meta-analysis.
    Lu DE; Cheng SW; Lin YS; Tu MW; Lee CH; Chen C; Chen KH
    Ann Hepatol; 2022; 27(5):100729. PubMed ID: 35700935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
    Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
    J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Qi X; Tang Y; An D; Bai M; Shi X; Wang J; Han G; Fan D
    J Clin Gastroenterol; 2014; 48(5):450-7. PubMed ID: 24172183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.